CRA is a proud exhibiting sponsor of this event.
Cecile Matthews is presenting during the session titled “What is the relationship between price and prevalence in non-oncology rare disease?”
Greg Bell is presenting during the session titled “Simplifying patient tracking,” showcasing RD Navigator.
For more information on this event, click here.
Paving the way for expanded GLP-1 coverage
GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) – but their most recent incarnations, which consist of both next generation GLP-1s and...